BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6668557)

  • 1. Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):515-27. PubMed ID: 6668557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1988; 21(4):337-42. PubMed ID: 3370743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):499-513. PubMed ID: 6668556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.
    Iven H; Brasch H; Engster J
    Cancer Chemother Pharmacol; 1985; 15(2):115-20. PubMed ID: 4017160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
    Chen ML; McGuire WP; Lad TE; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary pH and urine flow independent renal clearance of methotrexate in dogs.
    Lui CY; Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):159-71. PubMed ID: 4057055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance studies of methotrexate in dogs after multiple-rate infusion.
    Lui CY; Lee MG; Chiou WL
    Cancer Res; 1985 Apr; 45(4):1545-8. PubMed ID: 3978622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1990; 26(2):139-43. PubMed ID: 2189590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children.
    Winograd B; Lippens RJ; Oosterbaan MJ; Dirks MJ; Vree TB; van der Kleijn E
    Eur J Clin Pharmacol; 1986; 30(2):231-8. PubMed ID: 3709652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic interaction between methotrexate and 4'-(9-acridinylamino)methanesulfon-M-anisidide in the rabbit.
    Lee YJ; Chan KK
    Cancer Res; 1988 Sep; 48(18):5106-11. PubMed ID: 3409236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of piperacillin on the pharmacokinetics of methotrexate and 7-hydroxymethotrexate.
    Najjar TA; Abou-Auda HS; Ghilzai NM
    Cancer Chemother Pharmacol; 1998; 42(5):423-8. PubMed ID: 9771959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.
    Evans WE; Hutson PR; Stewart CF; Cairnes DA; Bowman WP; Rivera G; Crom WR
    Clin Pharmacol Ther; 1983 Mar; 33(3):301-7. PubMed ID: 6600662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1986; 17(3):218-22. PubMed ID: 3742705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats.
    Kim MM; Lee SH; Lee MG; Hwang SJ; Kim CK
    Biopharm Drug Dispos; 1995 May; 16(4):279-93. PubMed ID: 7548777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexate.
    Lena N; Imbert AM; Favre R; Cano JP; Carcassonne Y
    Eur J Cancer Clin Oncol; 1987 May; 23(5):481-5. PubMed ID: 3477455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemia.
    Evans WE; Stewart CF; Hutson PR; Cairnes DA; Bowman WP; Yee GC; Crom WR
    Drug Intell Clin Pharm; 1982 Nov; 16(11):839-42. PubMed ID: 6959800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of methotrexate after intravenous administration of methotrexate-loaded proliposomes to rats.
    Park JM; Ahn BN; Yoon EJ; Lee MG; Shim CK; Kim CK
    Biopharm Drug Dispos; 1994 Jul; 15(5):391-407. PubMed ID: 7981428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.